Medicalized Hunger

Genetic and hormonal drivers of appetite are well-characterized. Variants in the MC4R gene (melanocortin-4 receptor) produce clinical hyperphagia in carriers; about 1 in 1,000 people of European ancestry carry a disruptive MC4R variant, and those carriers have measurably higher hunger and weight trajectory independent of environment (Farooqi et al., NEJM, 2003). FTO variants are more common and produce smaller but measurable effects on appetite and adiposity (Frayling et al., Science, 2007).

Leptin resistance is another mechanism. In many people with higher baseline weight, circulating leptin is elevated (because fat cells produce it) but signaling in the hypothalamus is blunted, so the satiety message isn't received. This creates a state where you're eating and gaining but your brain still reads 'starving' (Myers et al., Cell Metabolism, 2012).

Ghrelin dysregulation, altered reward-system sensitivity to food cues, and differences in GLP-1 receptor signaling all contribute. A 2016 review in the journal Nature Reviews Endocrinology (Sumithran and Proietto) concluded that sustained appetite dysregulation in people with obesity is best understood as a chronic disease of energy regulation, not as a behavioral problem.

Conditions that can produce or amplify this pattern include hypothalamic obesity (after certain brain surgeries or tumors), Prader-Willi syndrome (rare, severe), craniopharyngioma, certain medications (antipsychotics, some antidepressants, corticosteroids), PCOS, and Cushing's disease. A thorough workup by an endocrinologist or obesity medicine specialist can identify these.

Get comprehensive lab work, even if you've had it before. Fasting insulin (not just glucose), leptin, HbA1c, TSH with free T3 and free T4, cortisol (AM, and sometimes 24-hour urine), lipid panel, inflammatory markers. If indicated, an OGTT with insulin measurements. Genetic testing for MC4R and related variants is available and worth considering if family history suggests it. This isn't optional background; it informs treatment.

Find a provider who treats this as medicine. Obesity medicine is a recognized specialty (ABOM board certification). So is endocrinology. Primary care providers without specialty training often default to diet and exercise advice that you've already tried. A specialist provider is worth the access friction.

Assume long-term treatment, not a short course. The medication isn't curing the dysregulation; it's managing it. Plan for the reality that you'll likely be on some form of therapy for years, which means monitoring, dose adjustments over time, and attention to musculoskeletal health (protein intake, strength training) to protect lean mass during sustained caloric reduction.

Support the medication with foundational behaviors that matter independently: 1.2-1.6 g per kg body weight of protein daily, structured strength training twice weekly, adequate sleep, and micronutrient-rich eating. These don't replace the medication; they amplify and protect against long-term side effects like sarcopenic weight loss.